72 related articles for article (PubMed ID: 9231076)
1. Antiretroviral effect of a gag-RNase HI fusion gene.
Schumann G; Cannon K; Ma WP; Crouch RJ; Boeke JD
Gene Ther; 1997 Jun; 4(6):593-9. PubMed ID: 9231076
[TBL] [Abstract][Full Text] [Related]
2. Capsid-targeted viral inactivation can eliminate the production of infectious murine leukemia virus in vitro.
VanBrocklin M; Federspiel MJ
Virology; 2000 Feb; 267(1):111-23. PubMed ID: 10648188
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of a Gag-nuclease fusion protein against retroviral infection in vivo.
Schumann G; Hermankova M; Cannon K; Mankowski JL; Boeke JD
J Virol; 2001 Aug; 75(15):7030-41. PubMed ID: 11435583
[TBL] [Abstract][Full Text] [Related]
4. [An experimental model for gene therapy of murine retroviral leukemias].
Aizaki K; Ikawa Y
Tanpakushitsu Kakusan Koso; 1995 Dec; 40(17):2679-85. PubMed ID: 8584720
[No Abstract] [Full Text] [Related]
5. In vitro inhibition of the replication of classical swine fever virus by capsid-targeted virus inactivation.
Wang YF; Wang ZH; Li Y; Zhang XJ; Sun Y; Li M; Qiu HJ
Antiviral Res; 2010 Feb; 85(2):422-4. PubMed ID: 19857524
[TBL] [Abstract][Full Text] [Related]
6. Mapping of a neurovirulence determinant within the envelope protein of a polytropic murine retrovirus: induction of central nervous system disease by low levels of virus.
Poulsen DJ; Robertson SJ; Favara CA; Portis JL; Chesebro BW
Virology; 1998 Sep; 248(2):199-207. PubMed ID: 9721229
[TBL] [Abstract][Full Text] [Related]
7. Expression of a murine leukemia virus Gag-Escherichia coli RNase HI fusion polyprotein significantly inhibits virus spread.
VanBrocklin M; Ferris AL; Hughes SH; Federspiel MJ
J Virol; 1997 Apr; 71(4):3312-8. PubMed ID: 9060701
[TBL] [Abstract][Full Text] [Related]
8. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
Sugahara D; Tsuji-Kawahara S; Miyazawa M
J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of dengue 2 virus capsid protein and staphylococcal nuclease fusion protein on dengue-infected cell cultures.
Qin CF; Qin E; Yu M; Chen SP; Jiang T; Deng YQ; Duan HY; Zhao H
Arch Virol; 2005 Apr; 150(4):659-69. PubMed ID: 15592886
[TBL] [Abstract][Full Text] [Related]
10. Folding the ribonuclease H domain of Moloney murine leukemia virus reverse transcriptase requires metal binding or a short N-terminal extension.
Goedken ER; Marqusee S
Proteins; 1998 Oct; 33(1):135-43. PubMed ID: 9741851
[TBL] [Abstract][Full Text] [Related]
11. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
12. Dynamic copy choice: steady state between murine leukemia virus polymerase and polymerase-dependent RNase H activity determines frequency of in vivo template switching.
Hwang CK; Svarovskaia ES; Pathak VK
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12209-14. PubMed ID: 11593039
[TBL] [Abstract][Full Text] [Related]
13. Targeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication.
Natsoulis G; Seshaiah P; Federspiel MJ; Rein A; Hughes SH; Boeke JD
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):364-8. PubMed ID: 7831291
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Friend virus replication by a compound that reacts with the nucleocapsid zinc finger: anti-retroviral effect demonstrated in vivo.
Ott DE; Hewes SM; Alvord WG; Henderson LE; Arthur LO
Virology; 1998 Apr; 243(2):283-92. PubMed ID: 9568028
[TBL] [Abstract][Full Text] [Related]
15. Escherichia coli RNase HI inhibits murine leukaemia virus reverse transcription in vitro and yeast retrotransposon Ty1 transposition in vivo.
Ma WP; Crouch RJ
Genes Cells; 1996 Jun; 1(6):581-93. PubMed ID: 9078387
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the co-incorporation of retroviral envelope glycoproteins.
Hatziioannou T; Russell SJ; Cosset FL
Virology; 2000 Feb; 267(1):49-57. PubMed ID: 10648182
[TBL] [Abstract][Full Text] [Related]
17. Reexamination of amphotropic murine leukemia virus neurovirulence: neural stem cell-mediated microglial infection fails to induce acute neurodegeneration.
Traister RS; Lynch WP
Virology; 2002 Feb; 293(2):262-72. PubMed ID: 11886246
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
19. Identification of the regions of Fv1 necessary for murine leukemia virus restriction.
Bishop KN; Bock M; Towers G; Stoye JP
J Virol; 2001 Jun; 75(11):5182-8. PubMed ID: 11333899
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor immunity against CT26 colon tumor in mice immunized with plasmid DNA encoding beta-galactosidase fused to an envelope protein of endogenous retrovirus.
Takeda J; Sato Y; Kiyosawa H; Mori T; Yokoya S; Irisawa A; Miyata M; Obara K; Fujita T; Suzuki T; Kasukawa R; Wanaka A
Cell Immunol; 2000 Aug; 204(1):11-8. PubMed ID: 11006013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
